TCL Archive Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS September 27, 1991
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003